Insulin plant – Frankfurt, Germany
| Client | Aventis Pharma Deutschland GmbH Frankfurt (Main)/Germany |
| Type of plant | New plant for the production of insulin glargine (trade name Lantus®) |
| Product | Recombinant insulin analog with depot effect |
| Production process | Microbial fermentation |
| Scope of work | General planner for design and construction, engineering „Lump sum“, basic and detail engineering, procurement (on behalf and on account), civil and construction, commissioning, qualification |
